XORTX Therapeutics Inc. filed a 6-K report on September 12, 2024, confirming its status as a foreign private issuer and compliance with SEC regulations. This filing is not deemed significant for equity investors.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.